External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ARVO 2023
Roche and Genentech at

ARVO 2023

April 23 - April 28
New Orleans, USA
arvo.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:45 PM
Duration 15mins La Nouvelle AB
Durable vision gains and greater fluid control with extended faricimab▼ dosing versus aflibercept in patients with diabetic macular edema
Lim J, Chen SJ, Steinle N, Jaffe G, Gerendas B, Abreu F, Camino A, Gibson K, Jain N, Shildkrot E, Souverain A, Tang Y, Willis J, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:00 PM
Duration 15mins La Nouvelle AB
Faricimab▼ Reduces Macular Leakage vs Aflibercept in Patients With Diabetic Macular Edema
Goldberg R, Kolomeyer A, Nudleman E, Csaky K, Willis J, Gibson K, Wang T, Haskova Z, Shildkrot E, Amador M, Mar F
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:15 PM
Duration 15mins La Nouvelle AB
Faster time to retinal fluid control with faricimab▼ in patients with DME in the phase 3 YOSEMITE/RHINE trials
Pollreisz A, Camino A, Gibson K, Mar F, Shildkrot E, Tang Y, Willis J, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:00 AM
Duration 15mins La Nouvelle AB
Port Delivery System With Ranibizumab in the Treatment of Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema: Primary Analysis Results of the Phase 3 Pavilion Trial
Emanuelli A, Holekamp N, Latkany P, Brittain C, Quezada-Ruiz C, Howard D, Santhanakrishnan A, Wetzel-Smith M, Malhotra V, Pieramici D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 15mins La Nouvelle AB
Visual function loss in geographic atrophy: learnings from lampalizumab trial data
Steffen V, Anegondi N, Ferrara D, Chakravarthy U
Ophthalmology | Geographic Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:45 AM
Duration 15mins La Nouvelle AB
Individualized faricimab▼ dosing up to every 16 weeks maintains robust anatomic and vision outcomes through 2 years in nAMD
Chaudhary V, Kotecha A, Willis J, Souverain A, Shildkrot E, Swaminathan B, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:30 AM
Duration 15mins La Nouvelle AB
A novel intravitreal anti-IL-6 monoclonal antibody for UME: preliminary results from the phase 1 DOVETAIL study
Sharma S, Suhler E, Lin P, Pauly-Evers M, Willen D, Peck R, Storti F, Rauhut S, Gott T, Passemard B, Macgregor L, Haskova Z, Silverman D, Fauser S, Mesquida M
Ophthalmology | Uveitis - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.